General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G).

PubWeight™: 2.51‹?› | Rank: Top 2%

🔗 View Article (PMID 15851773)

Published in Eval Health Prof on June 01, 2005

Authors

Penny S Brucker1, Kathleen Yost, John Cashy, Kimberly Webster, David Cella

Author Affiliations

1: Feinberg School of Medicine at Northwestern University, Evanston, IL 60201, USA. p-brucker@northwestern.edu

Associated clinical trials:

Stenting Malignant Jaundice for Quality of Life | NCT01459965

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors (iSTRIDE) | NCT05214937

Articles citing this

Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol (2013) 2.09

Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.08

Internet-Based Interactive Support for Cancer Patients: Are Integrated Systems Better? J Commun (2008) 1.72

Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res (2008) 1.65

A randomized trial of a Facebook-based physical activity intervention for young adult cancer survivors. J Cancer Surviv (2013) 1.60

The Women's wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. BMC Cancer (2017) 1.41

A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest (2008) 1.26

Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res (2010) 1.17

Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic. J Oncol Pract (2011) 1.17

Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes (2009) 1.16

Predictors of health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes (2008) 1.14

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12

Health-related quality of life in patients with high-grade glioma. Neuro Oncol (2008) 1.10

Evaluating the dimensionality of perceived cognitive function. J Pain Symptom Manage (2009) 1.08

Unmet spiritual care needs impact emotional and spiritual well-being in advanced cancer patients. Support Care Cancer (2011) 1.08

Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery. Health Qual Life Outcomes (2007) 1.03

A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study. J Pain Symptom Manage (2010) 1.01

New English and Spanish social health measures will facilitate evaluating health determinants. Health Psychol (2014) 1.00

Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study. Health Qual Life Outcomes (2010) 0.98

Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant (2010) 0.95

Determinants of quality of life in patients with advanced cancer. Support Care Cancer (2010) 0.95

Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. J Support Oncol (2010) 0.94

Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat (2011) 0.93

Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature. Support Care Cancer (2013) 0.91

Measuring psychosocial distress and parenting concerns among adults with cancer: the Parenting Concerns Questionnaire. Cancer (2012) 0.90

Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer. J Psychosom Res (2010) 0.88

Mediating processes of two communication interventions for breast cancer patients. Patient Educ Couns (2010) 0.88

The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma (2012) 0.88

Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N). Support Care Cancer (2007) 0.88

Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biol Blood Marrow Transplant (2013) 0.87

Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res (2010) 0.86

Health-Related Quality of Life of Food-Insecure Ethnic Minority Patients With Cancer. J Oncol Pract (2015) 0.86

The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res (2008) 0.85

What Factors are Associated With Quality Of Life, Pain Interference, Anxiety, and Depression in Patients With Metastatic Bone Disease? Clin Orthop Relat Res (2016) 0.84

Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia. Support Care Cancer (2008) 0.84

Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients. Crit Rev Oncol Hematol (2008) 0.83

Trajectories of quality of life among Chinese patients diagnosed with nasopharynegeal cancer. PLoS One (2012) 0.83

Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer (2012) 0.83

Predictors of quality of life for long-term cancer survivors with preexisting disabling conditions. Oncol Nurs Forum (2012) 0.82

Parenting changes in adults with cancer. Cancer (2015) 0.81

Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). J Surg Oncol (2012) 0.80

Health Literacy and Health-Related Quality of Life Among a Population-Based Sample of Cancer Patients. J Health Commun (2015) 0.80

Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation. J Support Oncol (2010) 0.79

Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature. Strahlenther Onkol (2013) 0.79

Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation. J Psychosoc Oncol (2015) 0.79

Depression and quality of life in cancer survivors: is there a relationship with physical activity? Int J Behav Nutr Phys Act (2007) 0.79

Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients. Gynecol Oncol (2013) 0.79

Feasibility and Preliminary Efficacy of an Online Intervention to Increase Physical Activity in Nova Scotian Cancer Survivors: A Randomized Controlled Trial. JMIR Cancer (2015) 0.79

The Clinician's Toolbox: Assessing the Sexual Impacts of Cancer on Adolescents and Young Adults with Cancer (AYAC). Sex Med (2015) 0.78

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI). Clinics (Sao Paulo) (2010) 0.78

Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians. Ther Adv Hematol (2012) 0.77

Examining health-related quality of life patterns in women with breast cancer. Qual Life Res (2017) 0.76

Acceptance and commitment therapy for adults with advanced cancer (CanACT): study protocol for a feasibility randomised controlled trial. Trials (2016) 0.76

Symptoms and quality of life of advanced cancer patients at home: a cross-sectional study in Shanghai, China. Support Care Cancer (2010) 0.76

Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy. Neuro Oncol (2010) 0.76

Fatalism, medical mistrust, and pretreatment health-related quality of life in ethnically diverse prostate cancer patients. Psychooncology (2015) 0.75

Contemplative self healing in women breast cancer survivors: a pilot study in underserved minority women shows improvement in quality of life and reduced stress. BMC Complement Altern Med (2014) 0.75

Case management to increase quality of life after cancer treatment: a randomized controlled trial. BMC Cancer (2017) 0.75

Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients. J Support Oncol (2015) 0.75

Feasibility and utility of telephone-based psychological support for people with brain tumor: a single-case experimental study. Front Oncol (2015) 0.75

Using a psychosocial registry as a data source for nurses. Clin J Oncol Nurs (2013) 0.75

Design, development, and feasibility of a spanish-language cancer survivor support group. Support Care Cancer (2015) 0.75

Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life. Rehabil Oncol (2016) 0.75

Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer. J Pers Assess (2012) 0.75

Review of 99 self-report measures for assessing well-being in adults: exploring dimensions of well-being and developments over time. BMJ Open (2016) 0.75

International SF-36 reference values in patients with ischemic heart disease. Qual Life Res (2016) 0.75

Symptom Management and Psychosocial Needs of Adults With Acute Myeloid Leukemia During Induction Treatment: A Pilot Study. Cancer Nurs (2016) 0.75

Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors. Breast Cancer Res Treat (2016) 0.75

Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach. Support Care Cancer (2016) 0.75

Attachment-oriented psychological intervention for couples facing breast cancer: protocol of a randomised controlled trial. BMC Psychol (2014) 0.75

Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. J Cancer Surviv (2017) 0.75

Quality of Life in Community-Dwelling Chinese American Patients with Cancer Pain. J Immigr Minor Health (2016) 0.75

Triathlon training for women breast cancer survivors: feasibility and initial efficacy. Support Care Cancer (2016) 0.75

In search of the sixth vital sign: cancer care in Romania. Support Care Cancer (2012) 0.75

Patient-reported outcomes in cancer care - hearing the patient voice at greater volume. Nat Rev Clin Oncol (2017) 0.75

Physical activity patterns and associations with health-related quality of life in bladder cancer survivors. Urol Oncol (2017) 0.75

Articles by these authors

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18

Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71

Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA (2003) 12.35

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet (2011) 12.13

Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med (2013) 10.74

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89

Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study. J Clin Oncol (2014) 6.64

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol (2007) 6.24

Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med (2002) 5.69

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes (2003) 5.58

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol (2011) 5.43

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol (2002) 4.69

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26

Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment (2011) 4.21

Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol (2010) 4.18

Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol (2002) 4.16

Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res (2009) 4.13

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2004) 3.85

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2009) 3.77

Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes (2007) 3.66

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65

Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma. J Clin Oncol (2012) 3.65

Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 3.65

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol (2004) 3.57

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial. J Clin Oncol (2013) 3.48

A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof (2005) 3.43

Assessment of neurological and behavioural function: the NIH Toolbox. Lancet Neurol (2010) 3.20

Item response theory analyses of physical functioning items in the medical outcomes study. Med Care (2007) 3.10

Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol (2005) 2.98

Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol (2007) 2.97

Development of a PROMIS item bank to measure pain interference. Pain (2010) 2.85

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.82

Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res (2009) 2.55

Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48

Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47

Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (2003) 2.41

Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol (2009) 2.39

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol (2008) 2.34

Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res (2003) 2.32

Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol (2005) 2.27

Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24

Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D. Med Care (2007) 2.22

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst (2002) 2.19

Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2010) 2.19

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17

A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol (2004) 2.14

Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res (2009) 2.10

Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.08

Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res (2011) 1.97

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96

Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol (2004) 1.95

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). Blood (2009) 1.94

Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer (2008) 1.89

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J (2003) 1.89

Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol (2007) 1.88

Issues in the development of an item bank. Arch Phys Med Rehabil (2003) 1.87

The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J Appl Meas (2010) 1.87

Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care (2007) 1.87

Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane). Cancer (2003) 1.81

Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc (2007) 1.79

Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol (2007) 1.77

Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue. Qual Life Res (2006) 1.70

Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr (2005) 1.70

Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol (2007) 1.70

Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. J Neurosci Nurs (2007) 1.70

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol (2005) 1.69

Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohort. Am J Respir Crit Care Med (2013) 1.68

An item response theory-based pain item bank can enhance measurement precision. J Pain Symptom Manage (2005) 1.68

Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting. Qual Life Res (2011) 1.68

The talking touchscreen: a new approach to outcomes assessment in low literacy. Psychooncology (2004) 1.67

Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form. Arthritis Care Res (Hoboken) (2011) 1.67

Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology (2002) 1.64

How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil (2011) 1.64

Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual Life Res (2009) 1.63

Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage (2007) 1.62

Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale. J Support Oncol (2005) 1.58

Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med (2011) 1.57

Analysis of differential item functioning in the depression item bank from the Patient Reported Outcome Measurement Information System (PROMIS): An item response theory approach. Psychol Sci Q (2009) 1.56

Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw (2008) 1.55

Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51

Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol (2003) 1.49

Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks. Qual Life Res (2010) 1.48

Real-time clinical application of quality-of-life assessment in advanced lung cancer. Clin Lung Cancer (2002) 1.47

The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Cancer J (2002) 1.45

Data mining derived treatment algorithms from the electronic medical record improve theoretical empirical therapy for outpatient urinary tract infections. J Urol (2011) 1.44

Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys Med Rehabil (2003) 1.44

Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc (2002) 1.44

Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc (2007) 1.43

An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol (2005) 1.43

IRT health outcomes data analysis project: an overview and summary. Qual Life Res (2007) 1.42